CA Stock MarketDetailed Quotes
PREV PreveCeutical Medical Inc
- 0.025
- +0.005+25.00%
15min DelayMarket Closed Jul 26 13:04 ET
13.50MMarket Cap-25000P/E (TTM)
0.025High0.020Low239.00KVolume0.020Open0.020Pre Close4.98KTurnover0.03052wk High0.05%Turnover Ratio539.90MShares0.01552wk Low-0.001EPS TTM11.75MFloat Cap0.200Historical HighLossP/E (Static)469.90MShs Float0.010Historical Low-0.002EPS LYR25.00%Amplitude--Dividend TTM-2.27P/B1Lot Size--Div YieldTTM
PreveCeutical Medical Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -51.79%142.11K | -9.04%963.12K | 54.31%352.7K | -69.09%153.12K | 83.00%294.74K | 17.93%1.06M | -21.01%228.57K | 668.10%495.4K | -45.40%173.79K | -57.32%161.06K |
| Selling and administrative expenses | -64.67%82.42K | -14.64%711.66K | 70.01%290.26K | -80.30%87.67K | 110.56%233.28K | 26.71%833.71K | -21.80%170.73K | 157.47%445K | -14.03%107.2K | -22.33%110.79K |
| -General and administrative expense | -64.67%82.42K | -14.64%711.66K | 70.01%290.26K | -80.30%87.67K | 110.56%233.28K | 26.71%833.71K | -21.80%170.73K | 157.47%445K | -14.03%107.2K | -22.33%110.79K |
| Research and development costs | -3.48%45.61K | 26.33%193.81K | 20.96%48.72K | 32.40%52.38K | 22.91%47.25K | -10.72%153.42K | -33.09%40.28K | 114.58%39.56K | -80.35%35.14K | -81.11%38.45K |
| Depreciation amortization depletion | 0.40%2.5K | -0.35%9.86K | -62.73%2.45K | 124.31%2.44K | 121.05%2.49K | 94.28%9.89K | 836.47%6.57K | -20.15%1.09K | -26.23%1.11K | -26.41%1.13K |
| -Depreciation and amortization | 0.40%2.5K | -0.35%9.86K | -62.73%2.45K | 124.31%2.44K | 121.05%2.49K | 94.28%9.89K | 836.47%6.57K | -20.15%1.09K | -26.23%1.11K | -26.41%1.13K |
| Other operating expenses | -1.19%11.58K | -22.66%47.79K | 2.55%11.27K | 9.12%10.64K | 9.53%11.72K | -1.80%61.79K | 8.44%10.99K | -1.26%9.75K | 128.32%30.35K | -63.88%10.7K |
| Operating profit | 51.79%-142.11K | 9.04%-963.12K | -54.31%-352.7K | 69.09%-153.12K | -83.00%-294.74K | -17.93%-1.06M | 21.01%-228.57K | -668.10%-495.4K | 45.40%-173.79K | 57.32%-161.06K |
| Net non-operating interest income (expenses) | -10.33%-80.94K | -30.45%-309.53K | -128.10%-79.69K | 73.25%-79.71K | 46.88%-73.36K | 49.18%-237.27K | 268.70%283.62K | -256.28%-298.02K | -8.09%-84.76K | -1.02%-138.12K |
| Non-operating interest expense | 10.33%80.94K | 30.45%309.53K | 128.10%79.69K | -73.25%79.71K | -46.88%73.36K | -49.18%237.27K | -268.70%-283.62K | 256.28%298.02K | 8.09%84.76K | 1.02%138.12K |
| Other net income (expenses) | 5.61%-12.35K | 99.02%-1.82K | -96.66%9.31K | -63.72%-6.81K | 95.67%-13.08K | 51.54%-185.28K | 966.78%278.84K | -195.87%-4.16K | 56.92%-158.08K | -1,758.68%-301.88K |
| Gain on sale of security | 5.61%-12.35K | -28.30%-1.82K | -97.07%9.31K | -63.72%-6.81K | 91.66%-13.08K | 99.33%-1.42K | 1,154.09%317.65K | -529.85%-4.16K | 56.92%-158.08K | -184.74%-156.84K |
| Special income (charges) | ---- | --0 | --0 | --0 | ---- | -8.37%-183.86K | -1,808.31%-38.82K | --0 | --0 | 13.09%-145.04K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -12.61%145.83K | --0 | ---- | ---- | -12.61%145.83K |
| -Less:Write off | ---- | --0 | ---- | ---- | ---- | --38.82K | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | --0 | --0 | --0 | ---- | 128.40%789 | --0 | --0 | --0 | --789 |
| Income before tax | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 69.95%-239.64K | 36.58%-381.19K | 15.21%-1.48M | 168.19%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K |
| Income tax | 0 | |||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 69.95%-239.64K | 36.58%-381.19K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K |
| Net income continuous operations | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 69.95%-239.64K | 36.58%-381.19K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 69.95%-239.64K | 36.58%-381.19K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 38.25%-235.4K | 13.97%-1.27M | -226.71%-423.07K | 69.95%-239.64K | 36.58%-381.19K | 14.20%-1.48M | 171.16%333.89K | -37,161.94%-797.57K | 45.44%-416.62K | -21.21%-601.06K |
| Diluted earnings per share | 56.00%-0.0004 | 33.33%-0.002 | 0 | 77.60%-0.0004 | -11.11%-0.001 | 0.00%-0.003 | 0 | -50,100.00%-0.002 | 20.40%-0.0008 | 35.71%-0.0009 |
| Basic earnings per share | 56.00%-0.0004 | 33.33%-0.002 | 0 | 77.60%-0.0004 | -11.11%-0.001 | 0.00%-0.003 | 0 | -50,100.00%-0.002 | 20.40%-0.0008 | 35.71%-0.0009 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg